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Abstract
Objective—Studies have shown that the inability of adipose tissue to properly expand during the
obese state or respond to insulin can lead to metabolic dysfunction. Artemisia is a diverse group of
plants that has a history of medicinal use. This study examines the ability of ethanolic extracts of
Artemisia scoparia (SCO) and Artemisia santolinifolia (SAN) to modulate adipocyte development
in cultured adipocytes and white adipose tissue (WAT) function in vivo using a mouse model of
diet-induced obesity.
Research Design & Procedures—Adipogenesis was assessed using Oil Red O staining and
immunoblotting. A nuclear receptor specificity assay was used to examine the specificity of SCO-
and SAN-induced PPARγ activation. C57BL/6J mice, fed a high-fat diet, were gavaged with
saline, SCO, or SAN for 2 weeks. Whole-body insulin sensitivity was examined using insulin
tolerance tests. WAT depots were assessed via immunoblotting for markers of insulin action and
adipokine production.
Results—We established that SCO and SAN were highly specific activators of PPARγ and did
not activate other nuclear receptors. After a one-week daily gavage, SCO- and SAN-treated mice
had lower insulin-induced glucose disposal rates than control mice. At the end of the 2-week
treatment period, SCO- and SAN-treated mice had enhanced insulin-responsive Akt serine-473
phosphorylation and significantly decreased MCP-1 levels in visceral WAT relative to control
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mice; these differences were depot specific. Moreover, plasma adiponectin levels were increased
following SCO treatment.
Conclusion—Overall, these studies demonstrate that extracts from two Artemisia species can
have metabolically favorable effects on adipocytes and WAT.
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Introduction
Adipocytes are dynamic insulin-sensitive cells that have endocrine properties and contribute
to whole body energy homeostasis. Obesity is the primary disease of fat cells and
significantly contributes to the development of type 2 diabetes mellitus (T2DM),
cardiovascular disease, and certain cancers. Many researchers have investigated anti-
adipogenic agents, including some botanicals, as potential therapeutics for decreasing or
preventing obesity. However, the prevailing current hypothesis is that disruption of
adipocyte differentiation limits adipose tissue expansion and leads to insulin resistance and
the development of T2DM [1–4].
Botanical extracts represent an alternative approach for the treatment or prevention of a
disease. Plant extracts are used by many cultures and have resulted in the development of
many drugs, including metformin. Metformin is a widely used T2DM drug that is derived
from French lilac. In a blinded screening study to investigate the effects of botanicals on
adipocyte differentiation, we identified plant extracts with substantial effects on
adipogenesis. Two of these extracts were Artemisia species, Artemisia scoparia (SCO) and
Artemisia santolinifolia (SAN). Many Artemisia species have been used in traditional
medicine in East Asia, and are reported to demonstrate anti-hyperglycemic [5, 6], anti-
obesity [7, 8], and anti-diabetic activities [5, 9]. Our studies revealed that both SCO and
SAN could promote adipocyte development in differentiating murine adipocytes. In
addition, these extracts specifically activate PPARγ, but did not modulate the activity of
other nuclear receptors. We also observed that SCO and SAN could increase adiponectin
(ADPN) secretion in vitro and in vivo. In a 2-week gavage study, SCO and SAN enhanced
insulin action in epididymal adipose tissue. These studies demonstrate that SCO and SAN
have a positive impact on adipocyte-related diseases by promoting adipocyte development
and increasing adiponectin levels and insulin action in adipose tissue.
Materials and Methods
Chemicals and reagents
Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Sigma-Aldrich (St.
Louis, MO). Bovine and fetal bovine sera were purchased from HyClone (Thermo
Scientific, Logan, UT). For immunoblotting, STAT5A, MAPK/ERK, and PPARγ antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The anti-adiponectin
antibody was obtained from Thermo Scientific (Rockford, IL). Anti-phospho-Akt-
Ser473(AktpS(473)), total Akt, and monocyte chemotactic protein-1 (MCP-1) antibodies
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were purchased from Cell Signaling Technology, Inc. (Danvers, MA). With the exception of
the mouse monoclonal anti-PPARγ IgG, all other antibodies were rabbit polyclonal IgGs,
and peroxidase-conjugated secondary antibodies to both species were purchased from
Jackson ImmunoResearch (West Grove, PA). The BCA and enhanced chemiluminescence
kits were from Thermo Scientific.
Preparation, source and characterization of the extracts
Artemisia scoparia Waldst. & Kit and Artemisia santolinifolia Turcz. ex Besser ethanolic
extracts were prepared at Rutgers University. Briefly, the herb was greenhouse grown from
seed and periodically harvested at the flowering stage, freeze dried and stored at −20°C. The
dried herb was extracted in 80% ethanol (1:20 w/v), at 50°C with sonication for 1 hour
followed by shaking at room temperature for 24 h. The solid material was removed by
centrifugation at 3000 g and the solvent was subsequently removed by evaporation. For in
vitro and cell culture experiments, the dried extracts were solubilized in 100% DMSO at a
concentration that was 1000-fold higher than experimental concentrations and then diluted
into the media. For animal studies, the extracts were solubilized in 20% Labrasol®
(Gattefosse, Lyon, France) and administered via gavage.
Nuclear receptor specificity assay
SCO and SAN were assessed for their ability to modulate the activities of all 48 human
nuclear receptors using a previously described Gal4 co-transfection assay system [10–12].
Both extracts were tested at 50 µg/ml and positive controls were included for characterized
ligands. DMSO was used as the vehicle control.
Cell culture
Murine 3T3-L1 preadipocytes were plated and grown to 2 days post-confluence in DMEM
containing 10% bovine serum. Medium was changed every 48–72 hours. Cells were induced
to differentiate using a standard MDI induction protocol [13]. Mature adipocytes were
maintained in DMEM supplemented with 10% FBS until utilized for experimentation. For
adipogenesis assays, the botanical extracts were added at the time of MDI induction and at
each media change until the cells were stained with Oil Red O (ORO) or harvested for
western blot analysis.
Oil Red O staining
An ORO stock was prepared as previously described [14]. Cell monolayers were aspirated,
rinsed with PBS, fixed in 10% formaldehyde/PBS, and rinsed under tap water. The
remaining water was aspirated, and the cells were incubated for 1 h in the working ORO
solution (0.3% in isopropanol). Following incubation, stain aspiration, and rinsing, cells
were examined by microscopy and scanned to produce the figures in this manuscript.
Animals and gavage
Thirty-six 16-week old male C57BL/6J-diet-induced obese (DIO) mice were purchased
from Jackson Laboratories (Bar Harbor, ME) and maintained on a purified high-fat diet
(HFD) containing 20 kcal% protein, 20 kcal% carbohydrate, and 60 kcal% fat (D12492;
Richard et al. Page 3






















Research Diets, Inc., New Brunswick, NJ) for the entire study. After one week in
quarantine, mice were housed four per cage in a temperature- and humidity-controlled room
with a 12-hour light/dark cycle. Mice were handled daily for 2 weeks and non-fasting body
weights were recorded daily. Non-fasting NMR (Bruckner Minispec) was recorded on day
14. Animals were gavaged (22 gauge plastic gavage needle, Instech Laboratories, Inc.
Plymouth Meeting, PA) with 20% Labrasol® daily for 7 days. On day 21, another non-
fasting NMR measurement was recorded and submandibular blood samples were collected.
Animals were randomized by non-fasting body weight (day 21) to one of 3 groups: 20%
Labrasol® (CTL; n=12), SCO (n=12), and SAN (n=12) and gavaged daily for an additional
2 weeks. Botanical extracts were prepared in 20% Labrasol® to increase bioavailability. All
animal studies were performed with approval from the Pennington Biomedical Research
Center Institutional Animal Care and Use Committee.
Animal Study Procedures
Non-fasted body weight was measured daily during the 2-week gavage study. Body
composition (NMR), fasting body weight, fasting plasma glucose, insulin, and adiponectin
levels were measured at the beginning (baseline measurements) and end of the 2-week study
period. One week following the initiation of experimental gavaging, and 4 hours after mice
received their last gavage, intraperitoneal insulin tolerance tests (IPITTs) were performed on
all animals. Briefly, a baseline blood glucose measurement was obtained via tail nick (0
minutes), and animals were then injected with 1U/kg insulin (Humulin R, Eli Lilly,
Indianapolis, IN). Blood glucose measurements were obtained via tail nick at 10, 20, 40, and
60 minutes post-injection. All blood glucose measurements were performed using a Bayer
Breeze 2 glucometer. Following 2 weeks of experimental gavage, mice were fasted
overnight and a fasted body weight, submandibular blood collection, and NMR
measurement were obtained for each mouse. Immediately following these procedures, mice
were gavaged with the appropriate extract or vehicle. Four hours after the gavage, mice were
injected with either 1 U/kg insulin or saline and euthanized via cervical dislocation 10–15
minutes after injections. Animals were then decapitated and trunk blood collected.
Retroperitoneal white adipose tissue (rWAT), inguinal adipose tissue (iWAT), and
epididymal adipose tissue (eWAT) depots were collected and immediately frozen in liquid
nitrogen.
Whole cell extract and tissue preparation
Adipocyte whole cell extracts and WAT lysates were prepared by either harvesting
adipocyte monolayers or homogenizing WAT in a non-denaturing extraction buffer
containing 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EGTA, 1 mM EDTA, 1% Triton
X-100, 0.5% Igepal CA-630, 1 mM phenylmethylsulfonyl fluoride, 1 µM pepstatin, 50
trypsin inhibitory milliunits of aprotinin, 10 µM leupeptin, 1mM 1, 10-phenanthroline, and
0.2 mM sodium vanadate. Protein content was determined by BCA protein assay (Bio-Rad
laboratories, Inc., Hercules, CA).
Gel electrophoresis and immunoblotting
Samples were separated on 7.5, 10, or 15% SDS-polyacrylamide gels (PA) and transferred
to nitrocellulose membranes. Results were visualized with horseradish peroxidase-
Richard et al. Page 4






















conjugated secondary antibodies and enhanced chemiluminescence. For native gel
electrophoresis, 5% PA gels were prepared without SDS. Additionally, SDS and reducing
agents were eliminated from the running and sample loading buffers.
Statistics
Data were graphed as mean ± SEM. The differences between treatment means were tested
using an ANOVA. Pairwise t-tests were performed to determine which means were different
when the ANOVA was statistically significant. A mixed model was used to model blood
glucose. Time, as a categorical variable, treatment, and time by treatment interaction were
included in the model. T-tests were performed at each time point on the least square means
from the model to determine if there were any statistically significant differences between
the treatments. All tests used p < 0.05 as the level of statistical significance.
Results
Artemisia extracts act as PPARγ agonists and promote adipogenesis of 3T3-L1 cells
We screened over 400 botanical extracts for their ability to activate PPARγ and modulate
adipogenesis in 3T3-L1 cells. Our results identified SCO and SAN as modulators of
adipocyte development. As shown in Figure 1A, SCO and SAN increased ORO staining of
3T3-L1 cells during adipogenesis relative to the vehicle control. Artemisia rutifolia and
GOP (grains of paradise) were not capable of promoting lipid accumulation relative to the
vehicle control. We also examined the ability of these botanical extracts to modulate the
expression of STAT5A and other adipocyte marker proteins, such as PPARγ and ADPN,
which are induced during fat cell differentiation. SCO and SAN substantially increased the
expression levels of the adipogenic marker proteins in 3T3-L1 adipocytes (Figure 1B).
Consistent with ORO results, addition of A. rutifolia did not increase PPARγ, adiponectin,
or STAT5A levels. Thus, SCO and SAN were selected for further investigation.
PPARγ belongs to the large nuclear receptor (NR) superfamily. We examined the ability of
SCO and SAN to modulate the activity of all forty-eight known human NRs by utilizing a
NR specificity assay. As previously demonstrated [11], activation and repression of NRs
were denoted as increases or decreases (greater than 3 standard deviations), respectively, in
fold change versus DMSO vehicle. SCO repressed and SAN stimulated the transactivating
activity of the many of the NR ligand binding domains (LBDs), but these marginal
modulations were not significant. However, SCO and SAN were capable of significantly
stimulating PPARγ. As shown in Figure 2, both SCO and SAN significantly activated the
LBD of PPARγ greater than 2 fold, and thus were extremely selective PPARγ agonists.
Physical and metabolic parameters of HFD-fed C57BL/6 mice treated with SCO and SAN
To investigate the ability of SCO and SAN to modulate adipocyte function in vivo, we used
the DIO C57BL/6J mouse model. SCO and SAN (500 mg/kg) were administered to male
mice daily via gavage for a period of two weeks. No significant effects on body weight,
physical appearance and activity were observed as a result of pre-treatment with Labrasol®
for one week. There were no significant differences in fasting body weight, fat mass (FM),
fat free mass (FFM), or the ratio of fat mass to lean mass (FM/LM) between the CTL and
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SCO or SAN-treated mice at the end of the two-week treatment (data not shown). However,
as shown in Figure 3, SCO-treated mice displayed increased insulin-induced glucose
disposal relative to control mice during an IPITT. Differences in the blood glucose levels of
SCO and CTL mice were statistically significant at the 20 and 60 min time points. Mice
treated with SAN also displayed slightly improved insulin-sensitive glucose disposal,
especially at time points between 20 and 60 minutes.
SCO and SAN increase insulin sensitivity in WAT in a depot specific manner
Following two weeks of botanical treatment, the mice were fasted overnight, and then
injected with saline or insulin 10 minutes prior to sacrifice. eWAT, rWAT, and iWAT were
collected and analyzed for Akt S473 phosphorylation. As shown in Figure 4, saline-injected
animals exhibited little to no AktpS(473) in any of the WAT depots. In response to insulin,
SCO- and SAN-treated mice displayed improved insulin sensitivity in eWAT when
compared to controls, as indicated by higher levels of AktpS(473). In rWAT and iWAT,
AktpS(473) levels were similar among all groups. Total Akt protein levels were not altered
by botanical treatment in any WAT depot.
SCO and SAN promote a beneficial adipokine profile in DIO mice
We also examined the effects of SCO and SAN on plasma ADPN levels. Plasma levels of
high molecular weight (HMW) and total ADPN were similar in SAN-treated and control
animals. SCO-treated mice exhibited elevated circulating levels of both total and HMW
ADPN (Figure 5) relative to controls, but this difference was not statistically significant. We
also examined MCP-1 protein levels in the WAT lysates. As shown in Figure 6, we
observed significant decreases in MCP-1 protein expression in the rWAT of SCO- and
SAN-treated mice relative to control animals. This trend was also observed in eWAT, but
not in iWAT (data not shown).
Discussion
Alterations in adipocytes and/or adipose tissue can have profound effects on metabolic
disease states. Improvements in adipocyte differentiation and adipocyte function represent
viable interventions for metabolic disease states including T2DM. For these reasons, we
examined the effects of a variety of botanical extracts on adipocyte development and
function. In a blinded screening study, we observed that ethanolic extracts from two related
Artemisia species, Artemisia scoparia and Artemisia santolinifolia can promote adipocyte
development in vitro. Moreover, extracts from these Artemisia species specifically activated
PPARγ, a transcription factor known to promote adipocyte development in vitro and in vivo
[15, 16]. Gavage studies in DIO mice were consistent with our in vitro observations and
indicated that SCO and SAN treated animals had reduced glucose levels following an insulin
tolerance test. We also observed increase insulin sensitivity as measured by Akt
phosphorylation in epididymal fat, but not other white fat depots. Adiponectin is a hormone
associated with cardioprotection and insulin sensitivity in mice in man [17, 18] and we
observed increases globular and high molecular weight adiponectin in mice treated with
SCO and SAN. These observations are consistent with the results of the insulin tolerance
test and examination of insulin action in adipose tissue. We predict the ability of SCO and
Richard et al. Page 6






















SAN to improve insulin action may be mediated by its ability to limit inflammation in
adipose tissue as our studies revealed that both Artemisia species reduced the expression of
MCP-1 in adipose tissue. Although other Artemisia species have been shown to have anti-
diabetic [5–7, 19] and insulin-sensitizing [20–22] activities, this is the first demonstration
that Artemisia SCO and SAN species can modulate adipocyte development and function.
There is also evidence to suggest that Artemisia scoparia can attenuate lipid accumulation in
liver and enhance hepatic insulin sensitivity [23]. Overall, our studies demonstrate that two
related Artemisia species have a positive impact on adipocyte related diseases by enhancing
differentiation of preadipocytes and increasing insulin sensitivity in adipose tissue in vivo.
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Abbreviations
T2DM Type 2 Diabetes Mellitus
SCO Artemisia scoparia extracts
SAN Artemisia santolinifolia extracts
PPARγ peroxisome proliferator-activated receptor gamma
ADPN adiponectin
DMEM Dulbecco’s Modified Eagle’s Medium
STAT5A signaltransducer and activator of transcription 5
MAPK mitogen-activated protein kinase
MCP-1 monocyte chemoattractant protein-1
BCA bicinchoninic acid
DMSO dimethyl sulfoxide
FBS fetal bovine serum
MDI 1-methyl-3-isobutylxanthine, dexamethasone, and insulin
ORO Oil Red O
DIO diet induced obesity
HFD high fat diet
NMR nuclear magnetic resonance
IPITT intraperitoneal insulin tolerance test
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i, e, and r WAT inguinal, epididymal, and retroperitoneal white adipose tissue
SDS sodium dodecyl sulfate
PA polyacrylamide
ANOVA ANalysis Of VAriance between groups
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Figure 1. SCO and SAN promote adipogenesis of 3T3-L1 cells
Differentiation of murine 3T3-L1 preadipocytes was induced using the standard induction
cocktail containing 50µg/ml of the indicated extracts (Artemisia rutifolia; RUT and Grains
of Paradise; GOP), untreated control (CTL), or DMSO vehicle (V). A) Cell monolayers
were subjected to ORO staining one week after induction. B) Western blot analysis was
performed on whole cell extracts (100 µg protein) prepared from cells that were harvested
one week after induction. The results represent three independently performed experiments.
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Figure 2. SCO and SAN specifically activate PPARγ
The ability of SCO and SAN to modulate the transactivation all 48 human NRs was assessed
using a NR specificity assay. HEK293 cells were co-transfected with Gal4 DNA binding
domain – NR fusions and luciferase reporter constructs. Extracts were tested at 50 µg/ml,
and DMSO was used as a vehicle control. The luciferase activity of each construct was
measured and normalized to the mock (vector alone), and then the fold change in signal
compared with DMSO was calculated (n = 4). Data are means +/− SEM (n = 4). Horizontal
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dashed lines represent +/− 3 S.D. of the luciferase activity measured following DMSO
treatment.
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Figure 3. SCO and SAN improve glucose disposal in response to an intraperitoneal insulin
injection
Mice were gavaged with 20% Labrasol® (CTL) in the presence or absence of SCO or SAN
daily for one week. Blood glucose levels were monitored at the indicated time points
following a single insulin injection of insulin. Data are presented as mean +/− SEM (n = 12).
*p ≤ 0.03, SCO versus CTL and **p ≤ 0.01, SCO or SAN versus CTL.
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Figure 4. SCO and SAN increase insulin-induced Akt phosphorylation in eWAT
Tissue extracts of eWAT, iWAT, and rWAT from CTL-, SCO- and SAN-treated mice were
subjected to Western blot analysis (50–150 µg protein). There were 6 mice per condition and
three animals per condition are shown. For each depot, the results for each antibody are from
the same exposure of the same blot. Densitometric analyses are shown to the right of each
blot; AktpS(473) band intensities were normalized by the respective total Akt band
intensities prior to comparison against CTL. Data are means +/− SEM (n = 3).
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Figure 5. SCO increases the plasma levels of HMW and total ADPN in DIO mice
Serum HMW and total ADPN, were separated by native PA gel electrophoresis (50 µg
protein) and SDS-PAGE, respectively, for HMW and total protein content, and visualized by
Western blot analysis. Densitometric analysis is shown below each blot; Data are means +/−
SEM (n = 3).
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Figure 6. SCO and SAN decrease MCP-1 levels in WAT
rWAT from CTL-, SCO-, and SAN-treated mice was subjected to Western blot analysis
(100 µg total protein/lane). Densitometric analysis is shown below the blot; MCP-1 band
intensities were normalized to the respective MAPK band intensities prior to comparison
against CTL. Data are means +/− SEM (n = 3).
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